New dermatological findings of <scp>MIS‐C</scp> : Can mucocutaneous involvement be associated with Severe Disease Course?-Reference-Cited by-同舟云学术

New dermatological findings of MIS‐C : Can mucocutaneous involvement be associated with Severe Disease Course?

Published:2022-03-15 Issue:2 Volume:63 Page:228-234
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Aust J Dermatology

Author:

Akçay Nihal¹^ORCID,Topkarcı Zeynep²^ORCID,Menentoğlu Mehmet Emin¹^ORCID,Oğur Mustafa¹^ORCID,Sofuoğlu Ayşe İrem¹^ORCID,Boydağ Güvenç Kübra¹^ORCID,Baydemir Canan³^ORCID,Şevketoğlu Esra¹^ORCID

Affiliation:

1. Department of Pediatric Intensive Care Unit, Bakırkoy Dr Sadi Konuk Research and Training Hospital University of Health Sciences Istanbul Turkey

2. Department of Dermatology, Bakirkoy Dr Sadi Konuk Research and Training Hospital University of Health Sciences Istanbul Turkey

3. Department of Biostatistics, Faculty of Medicine Kocaeli University Kocaeli Turkey

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13819

Reference11 articles.

1. World Health Organization (WHO)Coronavirus disease (COVID‐19) Situation Report 2020–104[Internet]. Available athttps://covid19.who.int/

2. Caring for Critically Ill Children With Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections’ Collaborative of the European Society of Pediatric and Neonatal Intensive Care*

3. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children

4. Center for Disease Control and Prevention: Multisystem Inflammatory Syndrome in Children (MIS‐C)[Internet]. [cited 2021 April 2)https://www.cdc.gov/mis‐c/hcp/index.html

5. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic